Temperature, ˚C

40.6 ± 3,5

40.7 ± 6.6

40,5 ± 4,9

0.971

Respiratory rate, cpm

23.7 ± 5.8

23.5 ± 5.8

23.9 ± 5.9

0.531

GCS

10.6 ± 3.4

11.5 ± 3.0

9.9 ± 3.5

<0.001

<0.001

<8

49 (25.3)

10 (11.4)

39 (36.8)

≥8

145 (74.7)

78 (88.6)

67 (63.2)

Sp02, %

90,8 ± 9.6

10.5 ± 3.5

11.6 ± 2.7

0.183

0.297

<90

44 (22.7)

22 (25.0)

22 (20.8)

≥90

150 (77.3)

66 (75.0)

84 (79.2)

Pupilla status, n (%)

0.916

Bilateral myosis

28 (14.4)

13 (14.8)

15 (14.2)

Bilateral mydriasis

22 (11.3)

11 (12.5)

11 (10.4)

Motor deficiency, n (%)

120 (61.9)

57 (64.8)

63 (59.4)

0.270

Treatment, n (%)

CCB (Nicardipine)

113 (58.2)

64 (72.7)

70 (66.0)

0.199

Insulin

43 (22.2)

0 (0.0)

43 (40.6)

0.007

Anti-seizure (Phenobarbital)

71 (36.5)

32 (36.4)

39 (36.8)

0.536

Anti-edematous (Mannitol)

72 (37.1)

26 (29.5)

46 (43.4)

0.003

Catecholamines

33 (17.0)

9 (10.2)

24 (22.6)

0.057

Mechanical ventilation

50 (25.7)

17 (19.3)

33 (31.1)

0.043